Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Odyssey Health

    Client Virtual Booth

    ODYSSEY HEALTH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Odyssey Health
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2372 Morse Ave. Irvine, CA 92614
    Telephone
    Telephone
    702-780-6559
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://odysseygi.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Odyssey Health Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
    Odyssey Health Gains Shareholder Approval for Asset Sale with Oragenics, Inc.

    https://www.accesswire.com/viewarticle.aspx?id=815839&lang=en

    ACCESSWIRE
    12 Dec 2023
    Share Share
    Odyssey Selects Syneos to Support NDA for Treatment of Concussion
    Odyssey Selects Syneos to Support NDA for Treatment of Concussion

    https://www.accesswire.com/viewarticle.aspx?id=804016&lang=en

    ACCESSWIRE
    16 Nov 2023
    Share Share
    Oragenics to Acquire Odyssey’s Neurological Drug Technology Pipeline
    Oragenics to Acquire Odyssey’s Neurological Drug Technology Pipeline

    https://www.businesswire.com/news/home/20231004015689/en

    BUSINESSWIRE
    05 Oct 2023
    Share Share
    Odyssey Health To Develop Intranasal Field- Deliverable Nerve Agent Antidote
    Odyssey Health To Develop Intranasal Field- Deliverable Nerve Agent Antidote

    https://www.globenewswire.com/news-release/2023/01/12/2587869/0/en/Odyssey-Health-Inc-To-Develop-Intranasal-Field-Deliverable-Nerve-Agent-Antidote.html

    GLOBENEWSWIRE
    12 Jan 2023
    Share Share
    Odyssey Provides a Year End Update on Company and Corporate Outlook for 2023
    Odyssey Provides a Year End Update on Company and Corporate Outlook for 2023

    https://www.globenewswire.com/news-release/2022/12/19/2576323/0/en/Odyssey-Health-Inc-Provides-a-Year-End-Update-on-Company-and-Corporate-Outlook-for-2023.html

    GLOBENEWSWIRE
    19 Dec 2022
    Share Share
    Odyssey Health Provides Update on Company and Drug Development
    Odyssey Health Provides Update on Company and Drug Development

    https://www.globenewswire.com//news-release/2022/11/23/2561613/0/en/Odyssey-Health-Inc-Provides-Update-on-Company-and-the-Progress-of-Concussion-Drug-Development.html

    GLOBENEWSWIRE
    23 Nov 2022
    Share Share
    Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma
    Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma

    https://www.globenewswire.com/news-release/2022/11/03/2547674/0/en/Odyssey-Health-Inc-Strengthens-Commitment-to-Odyssey-NeuroPharma-Through-Expansion-of-Executive-Team.html

    GLOBENEWSWIRE
    03 Nov 2022
    Share Share
    Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled
    Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled

    https://www.globenewswire.com/news-release/2022/11/01/2545494/0/en/Odyssey-Health-Inc-Files-Full-US-Patent-Application-on-Novel-Breath-Propelled-Intranasal-Brain-Drug-Delivery-Device.html

    GLOBENEWSWIRE
    01 Nov 2022
    Share Share
    Odyssey Forms Pharmaceutical Subsidiary Focused on Neurological Diseases
    Odyssey Forms Pharmaceutical Subsidiary Focused on Neurological Diseases

    https://www.globenewswire.com/news-release/2022/10/11/2531836/0/en/Odyssey-Health-Inc-Forms-Pharmaceutical-Subsidiary-Focused-on-Treating-Neurological-Diseases.html

    GLOBENEWSWIRE
    11 Oct 2022
    Share Share
    Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Devp
    Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Devp

    https://www.globenewswire.com/news-release/2022/09/30/2526366/0/en/Odyssey-Health-Inc-Makes-Statement-Regarding-its-Concussion-Drug-Development-Program.html

    GLOBENEWSWIRE
    30 Sep 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search